APA (7th ed.) Citation

Joerger, M., Huitema, A. D. R., Huizing, M. T., Willemse, P. H. B., de Graeff, A., Rosing, H., . . . Vermorken, J. B. (2007). Safety and pharmacology of paclitaxel in patients with impaired liver function: A population pharmacokinetic–pharmacodynamic study. British Journal of Clinical Pharmacology, 64(5), 622. https://doi.org/10.1111/j.1365-2125.2007.02956.x

Chicago Style (17th ed.) Citation

Joerger, M., A. D. R. Huitema, M. T. Huizing, P. H. B. Willemse, A. de Graeff, H. Rosing, J. H. M. Schellens, J. H. Beijnen, and J. B. Vermorken. "Safety and Pharmacology of Paclitaxel in Patients with Impaired Liver Function: A Population Pharmacokinetic–pharmacodynamic Study." British Journal of Clinical Pharmacology 64, no. 5 (2007): 622. https://doi.org/10.1111/j.1365-2125.2007.02956.x.

MLA (9th ed.) Citation

Joerger, M., et al. "Safety and Pharmacology of Paclitaxel in Patients with Impaired Liver Function: A Population Pharmacokinetic–pharmacodynamic Study." British Journal of Clinical Pharmacology, vol. 64, no. 5, 2007, p. 622, https://doi.org/10.1111/j.1365-2125.2007.02956.x.